Hedge Fund - Viking Global

Bridgebio Pharma Inc. (BBIO) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q4 (2025-12-31) $1,100,992,012 2.92% 14,393,934 $65.64
2 2025 - Q3 (2025-09-30) $829,889,477 2.16% 15,977,849 $48.77
3 2025 - Q2 (2025-06-30) $801,221,093 2.32% 18,555,375 $36.37
4 2025 - Q1 (2025-03-31) $762,454,314 2.42% 22,055,375 $33.72
5 2024 - Q4 (2024-12-31) $689,319,993 2.23% 25,120,991 $25.84
6 2024 - Q3 (2024-09-30) $639,580,431 2.33% 25,120,991 $26.25
7 2024 - Q2 (2024-06-30) $636,314,702 2.44% 25,120,991 $27.34
8 2024 - Q1 (2024-03-31) $776,741,042 2.89% 25,120,991 $34.01
9 2023 - Q4 (2023-12-31) $1,014,134,407 3.71% 25,120,991 $30.03
10 2023 - Q3 (2023-09-30) $662,440,533 2.68% 25,120,991 $28.38
11 2023 - Q2 (2023-06-30) $457,881,045 1.87% 26,620,991 $15.05
12 2023 - Q1 (2023-03-31) $441,376,031 2.07% 26,620,991 $11.66
13 2022 - Q4 (2022-12-31) $202,851,951 1.01% 26,620,991 $9.57
14 2022 - Q3 (2022-09-30) $264,613,000 1.22% 26,620,991 $10.39
15 2022 - Q2 (2022-06-30) $241,719,000 1.1% 26,620,991 $8.36
16 2022 - Q1 (2022-03-31) $270,203,000 1.09% 26,620,991 $10.26
17 2021 - Q4 (2021-12-31) $444,038,000 1.27% 26,620,991 $42.31
18 2021 - Q3 (2021-09-30) $1,247,726,000 3.42% 26,620,991 $53.60
19 2021 - Q2 (2021-06-30) $1,622,816,000 4.92% 26,620,991 $57.11
20 2021 - Q1 (2021-03-31) $1,639,853,000 4.88% 26,620,991 $65.42
21 2020 - Q4 (2020-12-31) $1,893,019,000 5.2% 26,620,991 $48.24
22 2020 - Q3 (2020-09-30) $998,820,000 3.6% 26,620,991 $31.46
23 2020 - Q2 (2020-06-30) $868,111,000 3.75% 26,620,991 $30.46
24 2020 - Q1 (2020-03-31) $772,009,000 4.01% 26,620,991 $31.01
25 2019 - Q4 (2019-12-31) $933,066,000 4.37% 26,620,991 $27.72
26 2019 - Q3 (2019-09-30) $571,553,000 2.97% 26,620,991 $27.66
27 2019 - Q2 (2019-06-30) $717,968,000 3.22% 26,620,991 $27.26

The displayed share prices are average quarterly stock market prices.